NIWOT, Colo., Oct. 31, 2016 -- Crocs, Inc. (NASDAQ:CROX) today announced that it will host a conference call to discuss the results of its third quarter ended September 30, 2016 on Wednesday, November 9, 2016 at 8:30 a.m. ET. The call participation number is (888) 771-4371. A replay of the conference call will be available two hours after the completion of the call at (888) 843-7419. International participants can dial (847) 585-4405 to take part in the conference call and can access a replay of the call at (630) 652-3042. All of the above calls will require the input of the conference identification number 43651803. The call also will be streamed on the Crocs website, www.crocs.com. An audio recording of the conference call will be available at www.crocs.com through November 9, 2017.
About Crocs, Inc.
Crocs, Inc. is a world leader in innovative casual footwear for men, women and children. Crocs offers a broad portfolio of all-season products, while remaining true to its core molded footwear heritage. All Crocs™ shoes feature Croslite™ material, a proprietary, revolutionary technology that gives each pair of shoes the soft, comfortable, lightweight, non-marking and odor-resistant qualities that Crocs fans know and love. Crocs celebrates the fun of being a little different and encourages fans to "Find Your Fun" in every colorful pair of shoes. Since its inception in 2002, Crocs has sold more than 300 million pairs of shoes in more than 90 countries around the world.
Visit www.crocs.com for additional information.
Investor Contact: Brendon Frey/ICR, Inc. (203) 682-8200 [email protected] Media Contact: Patrick Rich/Crocs, Inc. (303) 848-7000 [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



